PAF is a highly significant non-motor prodromal feature of synucleinopathy, with approximately 33–35% of patients phenoconverting to more widespread neurodegenerative synucleinopathies over time, most commonly to PD, DLB, or MSA [ 56 , 57 , 58 ].
← all excerpts
Skin-Based α-Synuclein Deposits Detection Across the Prodromal Continuum of Synucleinopathies: Updated Evidence and Perspectives.
1
—
—